Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 163 participants.

Also called NCT05911685

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 163 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05911685
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05911685. Allocation not applicable; no masking; primary purpose treatment. Start 2019-03-26 (actual); primary completion 2021-01-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder
Intervention (Device)
SeaLA™ left atrial appendage occluder
Lead sponsor
Hangzhou Dinova EP Technology Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05911685
Content hash
19c506f9b6512f12f065d91fd6a53fa42eca6fff7ef37282aa3d0d9003310560